Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

NCT07254793 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoid Leukemia
Acute Myeloid Leukemia
Acute Undifferentiated Leukemia (AUL)
Myelodysplastic Syndrome
Chronic Myeloid Leukemia
Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: Exercise Mobilized Prophylactic DLI
BIOLOGICAL: Standard Prophylactic DLI
BIOLOGICAL: Exercise Mobilized Therapeutic DLI
BIOLOGICAL: Standard Therapeutic DLI

Sponsor

University of Arizona